Agile Therapeutics, Inc. stock is up 6% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 9 December’s closed higher than November.
Agile Therapeutics, Inc. researches, develops, and commercializes prescription contraceptive products. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of line extensions and other products.